Sabin Sends More Marburg Vaccines for Rwanda’s Outbreak
31 oct. 2024 14h22 HE
|
Sabin Vaccine Institute
Photo caption: Rwanda Minister of State for Health, Yvan Butera, was among those who received Sabin’s investigational vaccine in the open-label clinical trial. WASHINGTON, Oct. 31, 2024 (GLOBE...
Sabin Vaccine Institute Delivers Marburg Vaccines to Combat Outbreak in Rwanda
05 oct. 2024 18h24 HE
|
Sabin Vaccine Institute
[Caption] Sabin Vaccine Institute delivered 700 doses of its Marburg vaccine to Rwanda on Oct. 5, 2024. WASHINGTON, Oct. 05, 2024 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute has provided...
NANO Nuclear Signs a Memorandum of Understanding with the Rwanda Atomic Energy Board to Develop a Robust Nuclear Energy Ecosystem within the Republic of Rwanda
15 août 2024 13h22 HE
|
NANO Nuclear Energy Inc.
NANO Nuclear and the Rwanda Atomic Energy Board will cooperate on educational, regulatory and physical development of the country’s nuclear energy infrastructure. New York, N.Y., Aug. 15, 2024 ...
BioNTech und CEPI erweitern Partnerschaft zur Stärkung des afrikanischen mRNA-Impfstoff-Ökosystems
29 mai 2024 08h00 HE
|
BioNTech SE
BioNTech und die Coalition for Epidemic Prepardness Innovations (CEPI) wollen die lokale Forschung und Entwicklung sowie die klinische und kommerzielle Herstellung potenzieller mRNA-Impfstoffe...
BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
29 mai 2024 08h00 HE
|
BioNTech SE
BioNTech and CEPI aim to enhance local R&D, clinical and commercial-scale manufacturing capacities to develop potential mRNA vaccines in Africa, for AfricaCEPI to fund up to $145 million to...
BioNTech erreicht Meilenstein in der Errichtung einer Produktionsstätte für mRNA-basierte Impfstoffe in Ruanda
18 déc. 2023 13h15 HE
|
BioNTech SE
Die Errichtung des ersten BioNTainers als Hightech-Produktionslösung für mRNA-Arzneimittel ist ein entscheidender Schritt zum Aufbau eines resilienten Impfstoff-Ökosystems in Afrika sowie in der...
BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda
18 déc. 2023 13h15 HE
|
BioNTech SE
Set-up of first BioNTainer as high-tech manufacturing solution for mRNA medicines is a critical step in establishing a resilient vaccine ecosystem in Africa and future pandemic preparednessBioNTech...
BioNTech weiht am 18. Dezember 2023 ersten afrikanischen Standort ein
12 déc. 2023 06h45 HE
|
BioNTech SE
MAINZ, Deutschland, 12. Dezember 2023 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen“) wird am Montag, den 18. Dezember 2023, den ersten afrikanischen Standort des...
BioNTech to Inaugurate First African Site on December 18, 2023
12 déc. 2023 06h45 HE
|
BioNTech SE
MAINZ, Germany, December 12, 2023 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will inaugurate its first African site in Kigali, Rwanda, on Monday, December 18th, 2023....
Global Typhoid Challenges in Focus at International Conference in Rwanda
05 déc. 2023 09h05 HE
|
Sabin Vaccine Institute
KIGALI, Rwanda, Dec. 05, 2023 (GLOBE NEWSWIRE) -- The 13th International Conference on Typhoid & Other Invasive Salmonelloses gets under way today in Kigali, Rwanda, with nearly 350...